Relatively absent from previous studies of the pharmacotherapy for bipolar disorder is
examination of the impact of comorbidity on treatment choices. This has occurred despite the …

Background Reducing hospitalizations and emergency room visits is important to improve
patient outcomes. This observational study examined the association between adherence to …

Objective: Extensive combination pharmacotherapy regimens for bipolar disorder have
gained increasing use in routine practice in ways that outpace data from evidence-based …

Objectives: We examined trends in prescription recommendations for treatment of bipolar
disorder (BD) in Canada during 2002–2010. Methods: Data collected by IMS Brogan in a …

Purpose To determining whether the addition of a long-acting injectable antipsychotic (LAI-
AP) has a positive effect on prognosis in bipolar disorder. Materials and methods Medical …

OBJECTIVE: As the limitation of lithium that is representative of the treatment in bipolar
disorder is known, the use of other mood stabilizers such as carbamazepine, valproate have …

Increased early-onset bipolar illness was seen in the US compared with the Netherlands
and Germany (abbreviated here as Europe), but other clinical characteristics, medication …

Background Studies have shown that rates of lithium use for bipolar disorder in the United
States declined through the 1990s as other mood stabilizing anticonvulsants and second …

BACKGROUND: Pharmacological treatment of bipolar depression is a complex and
controversial issue, and its real-world practice remains largely unknown. METHOD …

Objective The objective of this epidemiological study was to evaluate the current treatment
status as well as the acceptance of medication and satisfaction with life in outpatients with …